A Phase II Immunochemotherapy Study with Alemtuzumab, Fludarabine, Cyclophosphamide, and Doxorubicin (Campath-FCD) in Peripheral T-Cell Lymphomas.
Article
Weidmann, Eckhart, Hess, Georg, Krause, STefan W., Subklewe, Marion, Kruse, Judith, Soekler, Martin, Weisel, Katja, Kim, Soo-Zin, Dreyling, Martin H. and Jager, Elke (2006) A Phase II Immunochemotherapy Study with Alemtuzumab, Fludarabine, Cyclophosphamide, and Doxorubicin (Campath-FCD) in Peripheral T-Cell Lymphomas. Blood 108 (11), p. 2721.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Blood | ||||
| Publisher | AMER SOC HEMATOLOGY | ||||
| Place of Publication | WASHINGTON | ||||
| Volume | 108 | ||||
| Number of Issue or Book Chapter | 11 | ||||
| Page Range | p. 2721 | ||||
| Date | 2006 | ||||
| Date of publication | 19 Dec 2024 14:30 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) | ||||
| Identification Number |
| ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 69671 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric